COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,726 Articles (22,502 medRxiv, 8,224 bioRxiv)

Most recent first Previous |  Page 1169: Articles 11681-11690  | Next

Assessing the impact of temperature and humidity exposures during early infection stages on case-fatality of COVID-19: a modelling study in Europe
Liang, J., Yuan, H.-Y.
10.1101/2021.09.23.21264017 — Posted: 2021-09-26
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
Zeng, B., Gao, L., Zhou, Q., Yu, K., Sun, F.
10.1101/2021.09.23.21264048 — Posted: 2021-09-26 Discussion: Onsite
Evidence of Persisting Autoreactivity in Post-Acute Sequelae of SARS-CoV-2 Infection
Woodruff, M., Walker, T., Truong, A., Han, J., Dixit, A., Ramonell, R., Runnstrom, M., Rudoloph, M., Khosroshahi, A., Lee, F. E.-H., Sanz, I.
10.1101/2021.09.21.21263845 — Posted: 2021-09-26
Prevalence and risk factors for in-school transmission of SARS-CoV-2 in Massachusetts K-12 public schools, 2020-2021
Nelson, S. B., Dugdale, C., Bilinski, A., Cosar, D., Pollock, N. L., Ciaranello, A. L.
10.1101/2021.09.22.21263900 — Posted: 2021-09-26 Discussion: Onsite | Offsite
Prevalence of SARS-CoV-2 infection among people experiencing homelessness in Toronto during the first wave of the COVID-19 pandemic
Luong, L., Beder, M., Nisenbaum, R., Orkin, A., Wong, J., Damba, C., Emond, R., Lena, S., Wright, V., Loutfy, M., Bruce-Barrett, C., Cheung, W., Cheung, Y. K., Williams, V., Vanmeurs, M., Boozary, A., Manning, H., Hester, J., Hwang, S. W.
10.1101/2021.09.21.21263713 — Posted: 2021-09-26
Impact of vaccine hesitancy on secondary COVID-19 outbreaks in the US
Arribas, A. d. M., Aleta, A., Moreno, Y.
10.1101/2021.09.21.21263915 — Posted: 2021-09-26
Demographic characteristics of SARS-CoV-2 B.1.617.2 (Delta) variant infections in Indian population
Kumar, A., Asghar, A., Raza, K., Narayan, R. K., Jha, R. K., Satyam, A., Kumar, G., Dwivedi, P., Sahni, C., Kumari, C., Kulandhasamy, M., Motwani, R., Kaur, G., Krishna, H., Sesham, K., Pandey, S. N., Parashar, R., Kant, K., Kumar, S.
10.1101/2021.09.23.21263948 — Posted: 2021-09-26
Persistent while declined neutralizing antibody responses in the convalescents of COVID-19 across clinical spectrum during the 16 months follow up
Yang, Y., Yang, M., Peng, Y., Liang, Y., Wei, J., Xing, L., Guo, L., Li, X., Li, J., Wang, J., Li, M., Xu, Z., Zhang, M., Wang, F., Shi, Y., Yuan, J., Liu, Y.
10.1101/2021.09.18.21263550 — Posted: 2021-09-26
Association of comorbidities with COVID-19 infection rate and severity: nationwide cohort study with propensity score matching
Kim, J., Park, S. H., Kim, J. M.
10.1101/2021.09.22.21263946 — Posted: 2021-09-26
The Impact of New SARS-CoV-2 Variants on Vaccine Breakthrough: a pilot study on spreading infection in the communities
Ayass, M. A., Zhang, J., Zhu, K., Cao, W., Griko, N., Pashkov, V., Dai, J., Tripathi, T., Mosleh, L. A.
10.1101/2021.09.21.21263898 — Posted: 2021-09-26 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).